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ABSTRACT 
The in vitro response of lymphocytes correlates with patch testing results for nickel 
sensitivity when optimal concentrations are employed. The development of an in vitro test 
for nickel allergy allows further study into the mechanisms of delayed hypersensitivity 
without interference from the mediators of inflammation. 
Rigid controls and accurate calibration are necessary to insure reproducibility of results 
and these techniques are discussed. The potential usefulness of this in vitro test includes the 
simple evaluation of clinical allergy, investigation of immune surveillance, and the study of 
anergy associated with infectious and malignant diseases. 
Several recent contradictory reports have left 
unresolved problems concerning lymphocyte 
transformation by nickel ions. Pappas [1] de-
scribed a nonspecific effect of nickel acetate on 
lymphocytes from patients with and without 
nickel sensitivity. Aspegren and Rorsman [2]1ike-
wise reported nonspecific results with metal ion 
concentrations of 1 millimolar or less. At greater 
concentrations there was no reaction. Contradict· 
ing these findings is the work of Schopf et al [3], 
who reported no reaction of lymphocytes to nickel 
sulfate concentrations of 0.01 to 10 1-Lg per mi. A 
comparison of these different reports is difficult 
because of the variation in concentration of nickel 
ion used and the different nickel salts in each test. 
Amount of antigen used varies from 23,770 1-Lg with 
positive results, down to .01 1-Lg with negative 
results. The chemical forms of nickel used in· 
eluded nickel chloride, nickel acetate, and nickel 
sulfate. Because of the critical role of antigen 
concentration previously demonstrated in the phy-
tohemagglutinin system [4], we felt that these 
disparate results could be explained best by the 
wide variation in ion concentration used in the 
different techniques. 
The specific aims of the studies reported in this 
communication were threefold : to define the speci-
ficity of the lymphocyte response to nickel ions, to 
determine the optimal concentration, and to eval-
uate the dynamics of the response of antigen. A 
fourth long-range goal was the development of an 
in vitro system to study hypersensitivity to nickel 
and the immune response. 
MATERIALS AND METHODS 
Eight patients were studied. They all had a clinical 
history of nickel sensitivity confirmed by patch testing 
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and a normal phytohemagglutinin (PHA) response (to 
assure validity of the in vitro response and rule out drug 
or infective interference) . One patient was on systemic 
steroids at the time of the initial evaluation and the 
studies were repeated after she was off steroids. 
Control subjects included healthy young adults and 
patients with various dermatologic conditions including 
psoriasis, neurodermatitis, drug reactions, and early 
mycosis fungoides. All control subjects had a normal 
PHA response and no history of nickel dermatitis . 
Lymphocytes were cultured by modifications of the 
method of Bach and Hirschhorn [5] and Girard et al [6]. 
Blood was drawn in a syringe containing heparin and 
Dextran 40 and allowed to sediment for 1-2 hours to 
obtain the huffy coat. Cultures contained 2.5 million cells 
from the huffy coat, 20% autologous plasma, Eagle's 
minimal essential media with added Hanks ' salts, L-
glutamine, Streptomycin, and antigen as indicated be-
low. Triplicate 4-ml cultures in 12-ml capped tissue 
culture tubes were used throughout. Initial studies of 
antigen concentration encompassed the range from .01 
llg to 23.77 mg nickel chloride per 4 mi. The optimal 
concentrations were standardized at levels of 80 llg, 40 
llg, 10 llg, and 1 llg per culture and these are the results 
included in this paper. The tubes were incubated for six 
days at 37° C. 
At two hours prior to cell harvest, 1.5 microcuries of 
tritiated thymidine (thymidine-methyl H •, New Eng-
land Nuclear Corporation, Boston, Massachusetts- S. A. 
20 Ci/mM) were added to each tube. After incubation for 
two hours the cells were washed and precipitated with 
10% TCA. The precipitate was solubilized with NCS 
solubilizer, transferred to scintillation vials, and diluted 
with 5.5 ml Bray's solution [7]. The vials were then 
counted on a Packard tri -carb scintillation spectrometer 
model No. 3310 (setting efficiency of 47.5%). Acid 
precipitable counts per minute were used to calculate the 
results which are presented as percentages above and 
below control culture values. 
RESULTS 
The results of the six-day lymphocyte cultures 
are given in Tables I and II. The results are 
expressed in the average counts per minute of the 
triplicate samples for the control tubes and as 
multiples of the average control values for the 
tubes containing PHA and antigen. The optimal 
concentration of nickel was found to be between 40 
to 120 1-Lg per culture. 
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TABLE I 
Lymphocyte cultures in nickel-sensitive patients 
Control values expressed as counts per minute per culture. Experimental values expressed as a multiple of the 
control value. 
LM 
Patient BP SD JD BMC PC GM LG 
I II 
Control without antigen 114 1564 492 llO 547 . 124S 39 210 32 
( cpm/culture) 
Control with PHA 36x 19 x 12S x Sx 33l x 1S6 x 34 x 177 x 2SS x 
Nickel 120 l'g/culture 9x ND ND ND ND ND ND ND lOO x 
Nickel SO ~tg/culture 9x 
Nickel40 ~tg/culture 7x 
NickellO~tg/culture 1.4 x 
ND-Not done. 
TABLE II 
Lymphocyte cultures in controls 
23x 
17 x 
5x 
Control values expressed as counts per minute per 
culture. Experimental values expressed as a multiple 
of the control value. 
Patient JB JP AC SW OR PC 
Control without 751 130 217 129 329 224 
antigen 
( cpm/culture) 
Control with 33 x 60 x 154 x 37 x 28 x 4l x 
PHA 
Nickel 120 !Lg/4 1.4 x 2x ND ND ND ND 
ml 
Nickel so !Lg/4 ND 2x 1x 1x ND ND 
ml 
Nickel 40 !Lg/4 1.3 x 1.7 x 1.3 x 0.3x 0.9 x 1.2 x 
ml 
Nickel 10 !Lg/4 1.2 x 0.9x 0.7x 0.4 x l.lx 0.7 x 
ml 
ND-Not done. 
In Table I are the results from the nickel-sensi-
tive patients. Generally, positive results to specific 
antigens are in the range of 5 to 10 times control 
values or more. Nonspecific stimulants, like PHA, 
have a much higher percentage of cells responding, 
and values of 50 to 100 times controls are common 
[8). The effect of steroids on lymphocyte stimula-
tion is seen in patient LM. At the time of initial 
culture she was on Prednisone 40 mgm per day to 
control her disease, and a depression of PHA 
response is seen without an apparent depression of 
nickel response. Repeated studies when the pa-
tient was off steroids showed a normal PHA 
response, and repeated positive nickel response in 
the optimal concentration range confirmed initial 
impressions. 
In Table II are the results from the control 
patients . We were unable to confirm the results of 
Pappas et al which indicated that in controls or 
nickel-sensitive patients a nonspecific response 
occurred at 120 !Lg/4 mi. This concentration was 
31x 36 x ND ND 62x 16x ND 
lS x ND 27 x 14 x SO x 2x 132 x 
13 x 27 x lO x 5x ND 1.4 x SO x 
subsequently omitted from routine studies and 
lower concentrations were used to better delineate 
the optimal response curve. Consistently negative 
responses were obtained in these control cultures 
at the optimal levels for stimulation in nickel-sen-
sitive patients . 
DISCl'SSION 
In many instances, in vitro testing techniques 
enhance knowledge of biologic mechanisms. The 
skin test for contact allergy is simple and simu-
lates the clinical disease. However, it may not 
allow an analysis of the pathologic mechanism 
because of the interplay of many diverse factors. 
Critical among these is the role of the inflamma-
tory phase which causes the skin wheal. 
The sensitivity of lymphocyte transformation 
allows more precise analysis, although an adequate 
system of controls must be used to insure validity 
of the results. A nonspecific stimulator of the 
thymic limb such as PHA must be used as a 
control to insure that the system can respond and 
that negative results are not due to generalized 
anergy. 
Other nonspecific stimulators have been de-
scribed [9, 10] including more recently mercuric 
ion [11) and under investigation is nickel ion. 
Contradicting previous work is the recent report 
on specificity of the response to nickel acetate and 
sulfate [12) and our present study with nickel 
chloride. 
In both specific and nonspecific lymphocyte 
transformation the concentration of antigen has 
been found to be critical [13, 14). With antigenic 
stimulus the concentration plays an important role 
in the extent of blast transformation with a low 
response to low antigen concentration and toxic 
depression of response at high concentrations [15]. 
With this variable response related to antigen 
concentration the wide range of nickel concentra-
tion used in the various papers in the literature 
becomes of prime interest. With the possibility 
that the nonspecific stimulation was due to a toxic 
response, we elected to use initially a wide range of 
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cbncentrations of antigen to parallel previous 
studies. Several normal volunteers were tested on 
numerous occasions to encompass the full range of 
antigen described in the literature. These primary 
studies, using the broad range of concentrations, 
d'etermined the optimal concentrations and ruled 
out toxic nonspecific stimulation or lack of stimu-
l~tion at high levels of antigen concentration. The 
Jilek of a nonspecific response in normal controls 
prompted this study. Although we had no explana-
tion for the difference in our findings from those of 
other authors, we felt that the difference could be 
related to differences between the various salts of 
nickel. We used the same salt in the in vivo and in 
vitro testing. 
In addition to the need to determine the optimal 
concentration of antigen, adequate controls must 
b;e done on each patient to rule out a depressed 
response due to various interfering factors. The 
most elegantly studied of these blocking factors 
have been rubella virus infections, and other vi-
ruses are thought to act similarly [16_]. Likewise, 
other infections, including histoplasma [17] and 
mycoplasma [18], can depress a normal blast re-
sponse. Chronic diseases of many types and ma-
lignancies also depress the lymphocyte response 
[19-25]. These can be ruled out with an adequate 
system of controls. 
Careful attention must also be paid to concur-
rent drug therapy such as steroids [26], chloroquin 
[27], and others that have been shown to depress 
transformation. Patient LM demonstrated the 
depression of PHA responsiveness by concurrent 
steroid therapy and, most interestingly, continued 
to manifest lymphocyte transformation to nickel 
while on steroids. Repeat studies when the patient 
was off steroids showed reversion to normal PHA 
responsiveness. None of the other patients were on 
systemic drugs that might interfere with the test. 
The confirmation of in vitro responses to contact 
allergens allows for further study of these re-
sponses at the cellular level and potentially opens 
the door to future manipulations of those reac-
tions. 
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